Labcorp (LH) announced the appointment of Victor Bulto, a seasoned pharmaceutical executive and member of Novartis’ executive leadership team, to its Board of Directors, effective December 1, 2025. Bulto currently oversees Novartis’ (NVS) U.S. business.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LH: